Form D · Biotechnology
Logical Therapeutics Inc
Waltham, MA · CIK 0001405056
Offering snapshot reported May 21, 2010 · SEC filing
- Reported sold
- $10M Offering amount: $16.9M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 14, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2010 | Initial | $10,000,000 | No comparison | 7 | SEC filing |
| Aug 4, 2009 | Amendment | $32,537,580 | No comparison | 7 | SEC filing |
| Jun 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142401
Source: Form D, filed May 21, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Martin Edwards | Director |
| Bryant Fong | Director |
| Lutz Giebel | Director |
| Carolyn Green | Executive |
| Peter Lankau | Director, Executive |
| Paul Schmitt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
300 Second Avenue
Waltham, MA, 02451
Waltham, MA, 02451